Androski Lindsayinsider trades
In SEC Form 4 filings, Androski Lindsay is listed as President and CEO of Arbutus Biopharma Corp (ABUS). Androski Lindsay reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 7.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ABUSArbutus Biopharma Corp | President and CEO | 6 | Oct 7 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-23
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ABUSArbutus Biopharma Corp | Oct 1 | Oct 7 | D | 24,655 | $5.00 | $123,275 | 47,682 | No | Form 4 |
| ABUSArbutus Biopharma Corp | Sep 18 | Sep 23 | M | 116,408 | $3.20 | $372,506 | 144,408 | No | Form 4 |
| ABUSArbutus Biopharma Corp | Sep 18 | Sep 23 | M | 10,456 | $4.39 | $45,902 | 154,864 | No | Form 4 |
| ABUSArbutus Biopharma Corp | Sep 18 | Sep 23 | F | 82,527 | $5.07 | $418,412 | 72,337 | No | Form 4 |
| ABUSArbutus Biopharma Corp | Sep 18 | Sep 23 | M · derivative | 116,408 | $3.20 | $372,506 | 194,014 | No | Form 4 |
| ABUSArbutus Biopharma Corp | Sep 18 | Sep 23 | M · derivative | 10,456 | $4.39 | $45,902 | 61,244 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.